Avecho Biotechnology Limited has released a press release.
Receipt of Research & Development Tax Incentive
Earlier from Avecho Biotechnology
- Avecho completes treatment for Phase III interim analysis
- Expiry of Listed Options
- March 2026 Quarterly Activities Report & Appendix 4C
- Avecho completes recruitment for Phase III interim analysis
